Sean Gill

Senior Clinical Scientist
CSL Behring
King of Prussia, Pennsylvania, United States

Presentation(s):

• PB0541 - IX-TEND: A Phase IV Observational, Long-term Follow-up Study on the Safety and Efficacy of Etranacogene Dezaparvovec in Patients with Hemophilia B

  Monday, June 24, 2024
  13:45 – 14:45 ICT